Concepedia

Gopinath Ranganna

GR

3

Publications

68

Citations

3

H-Index

2018

Active since

Affiliations

Mylan (United States)(Current)

Biocon (India)

University of Freiburg

Mylan (United Kingdom)

University Medical Center Freiburg

Gopinath Ranganna is an author at Mylan (United States) specializing in pharmacokinetics, pharmacotherapy, and medicine.

ORCID

Top concepts

Publications per year

2018–2021

3

Publications

3

A pharmacokinetics and pharmacodynamics equivalence trial of the proposed pegfilgrastim biosimilar, MYL-1401H, versus reference pegfilgrastim

Cornelius F. Waller, Renger G. Tiessen, Tracey E. Lawrence et al. · Journal of Cancer Research and Clinical Oncology · 2018 · 30 citations · Full text

, , +4

Randomized phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H in the prophylactic treatment of chemotherapy-induced neutropenia

Cornelius F. Waller, Gopinath Ranganna, Eduardo J. Pennella et al. · Annals of Hematology · 2019 · 25 citations · Full text

Pharmacokinetic and pharmacodynamic bioequivalence of biosimilar <scp>MYL‐1601D</scp> with <scp>US</scp> and <scp>European</scp> insulin aspart in healthy volunteers: A randomized, double‐blind, crossover, euglycaemic glucose clamp study

Ulrike Hövelmann, Yaron Raiter, Anoop Chullikana et al. · Diabetes Obesity and Metabolism · 2021 · 13 citations · Full text

Rows per page

1–3 of 3